While there have been several trials that have been terminated, only CYDY keeps moving along. With the volume of data now available to the fda, I can't understand why LL cannot be prescribed for certain groups of patients. What the hell is next, trial by type of melanin ?

It's the dosage...... no it's the syringe.
It's the severity...... no it's the age of the patient.